AU Stock MarketDetailed Quotes
OSLOB OncoSil Medical Ltd
- 0.002
- 0.0000.00%
20min DelayMarket Closed Oct 31 15:00 AET
8.97MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.002Pre Close0.00Turnover0.00652wk High0.00%Turnover Ratio4.48BShares0.00252wk Low--EPS TTM7.88MFloat Cap0.006Historical High0.00P/E (Static)3.94BShs Float0.002Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About OncoSil Medical Ltd Company
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.
Company Profile
SymbolOSLOB
Company NameOncoSil Medical Ltd
Founded2005
MarketASX
Employees22
Fiscal Year Ends06-30
Address7 Eden Park Drive Level 5
CitySydney
CountryAustralia
Zip Code2113
Phone+61 289359629
Websitehttps://www.oncosil.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- Nigel Lange
- Executive Director, Chief Executive Officer and Managing Director
- --
- Dr. Jon Bell
- Chief Medical Officer
- --
- Christian Dal Cin
- Chief Financial Officer
- --
- Douglas Cubbin
- Non-Executive Chairman of the Board
- --
- Dr Gabriel Liberatore
- Non-Executive Director
- --
- David Turner
- Global Head of Medical Affairs
- --
- Renzo DiCarlo
- Head of Transformation
- --
- Henk Tissing
- Global Head of Clinical Affairs
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data